News

Gramercy Funds Management Reaches Major Settlement with Peru

Gramercy Funds Management Reaches Major Settlement with Peru

Gramercy Funds Management Reaches Settlement with the Republic of Peru

In recent news, Gramercy Funds Management LLC, along with Gramercy Peru Holdings LLC, collectively known as Gramercy, has successfully settled an international arbitration award with the Republic of Peru. This settlement resolves significant disputes stemming from Gramercy's investment in Peruvian agrarian reform bonds, valued at approximately 9,600 bonds. The issues were brought to arbitration under the United States–Peru Trade Promotion Agreement, emphasizing the importance of international treaties in protecting investors’ rights.

The Arbitration Process and Its Outcomes

This arbitration, designated ICSID Case No. UNCT/18/2, was a notable undertaking that culminated in a ruling dated December 6, 2022. This ruling demanded that Peru pay Gramercy damages alongside costs related to the investment. To further complicate matters, the award included a stipulation for compound interest on the primary financial award at an annual rate of 7.22%. The decision marked a significant moment in the landscape of investment protections provided under international law.

Settlement Agreement Details

Under the terms set out in the newly reached agreement, the Republic of Peru will remit a total of $85 million to Gramercy. The process commenced with an initial payment of $45 million, executed on a mutually agreed date, while the remaining balance will be settled based on a structured payment plan established by the parties. This plan is further elaborated in the Stipulated Judgment documented in the D.C. District Court, where proceedings were initiated to ensure enforcement of the award.

Gramercy's Position on the Settlement

Expressing their satisfaction with the outcome, Gramercy stated that they are pleased the constructive dialogue resulted in a resolution that benefits both, the firm and its investors. This amicable settlement underscores Gramercy’s commitment to enhancing its stakeholder relationships and maintaining transparency throughout the investment process.

About Gramercy Funds Management

Based in Greenwich, Connecticut, Gramercy is a prominent player in the global emerging markets investment scene. With an impressive $6 billion in assets under management, Gramercy has established offices in key locations including London, Buenos Aires, Miami, West Palm Beach, and Mexico City. Founded in 1998, the firm aims to furnish investors with a more effective approach to navigate emerging markets. The firm is dedicated to delivering attractive risk-adjusted returns while ensuring a robust and transparent institutional platform.

Investment Strategies Offered

Gramercy provides a variety of investment strategies across emerging market asset classes. These include multi-asset options, private credit, public credit, and special situations, thereby catering to the diverse requirements of their clientele. Their mission extends beyond mere financial returns, aiming to positively influence the well-being of clients, their portfolio investments, and their team members.

Commitment to Responsible Investing

As a Registered Investment Adviser recognized by the U.S. Securities and Exchange Commission, Gramercy holds itself to high standards of responsible investing. The firm is proud to be a Signatory of the Principles for Responsible Investment and the Net Zero Asset Managers initiative. Additionally, they support the Task Force on Climate-Related Financial Disclosures, showcasing their dedication to sustainability and ethical investment practices.

Client Engagement and Transparency

Through its operations, Gramercy seeks to establish a transparent relationship with clients, fostering an environment where investor interests are prioritized. As markets continue to evolve, Gramercy stands ready to adapt and innovate, ensuring they remain at the forefront of investment management.

Frequently Asked Questions

What is the significance of the settlement between Gramercy and Peru?

The settlement resolves a major arbitration award, allowing Gramercy to secure $85 million while reinforcing the protection of investor rights under international agreements.

How much did Gramercy initially receive from Peru?

Gramercy received an initial payment of $45 million as part of the settlement agreement with Peru.

What does Gramercy specialize in?

Gramercy specializes in emerging markets investments, offering various strategies that prioritize risk-adjusted returns for investors.

Where are Gramercy’s offices located?

Gramercy has offices in Greenwich, London, Buenos Aires, Miami, West Palm Beach, and Mexico City, enhancing their global reach.

How does Gramercy approach responsible investing?

Gramercy is committed to responsible investing and holds membership in several sustainability initiatives to promote ethical practices in finance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Synova Global Taps Eventus for Top Trade Surveillance

Updated Category News Views 144

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Continue Reading
Cambiotics Launches Key Trial on Reducing PFAS in Firefighters

Updated Category News Views 44

Pioneering Efforts to Combat 'Forever Chemicals' Cambiotics is stepping into some uncharted territory—tackling the tricky problem of PFAS accumulation in firefighters. If you’ve been following this, PFAS, or per- and polyfluoroalkyl substances, have been living rent-free in our bodies for years. Used in firefighting equipment and foams, these chemicals stick around,...

Continue Reading
ZBS Group Takes Over Rabinowitz’s CPA Practice with Bold Moves

Updated Category News Views 44

Transitioning Power in the CPA World Let's cut to the chase—when a seasoned CPA like Joseph Rabinowitz picks up the phone to secure a succession partner, it's a big deal. Enter ZBS Group LLP, steered by Michael Zaidman, which isn't a stranger to these waters, undertaking their fourth CPA practice acquisition through Rabinowitz's corner of the accounting universe....

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 44

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading
Cerbo's AI Scribe Expands to Telehealth Success

Updated Category News Views 46

Cerbo Enhances Telehealth With AI Scribe Expansion The digital healthcare playground looks like it's getting a nudge toward efficiency with Cerbo's latest move. Just when you thought telehealth couldn't get much sharper, these folks have drawn a line in the sand with their AI Scribe, which now makes its presence felt in virtual visits. No more juggling a dozen screens...

Continue Reading
SportsMed Expands to 58 Clinics, New Opening in Jersey City

Updated Category News Views 28

SportsMed Physical Therapy Expands with New Clinic Well, here we are, talking about expansion. And not just any expansion—I'm talking about SportsMed Physical Therapy flexing its muscles in Jersey City Heights, boosting their count to 58 clinics scattered across New Jersey and Connecticut. It's like watching a network of care roots spreading deeper into the region, and...

Continue Reading
Geopolitical Talks Shake Oil Market, Refine Stocks' Path

Updated Category News Views 92

Diplomacy Takes Center Stage So here we are again, riding the rollercoaster of geopolitics that's jerking the oil market around like a marionette. With the U.S. and Iran allegedly chatting—mind you, with a ton of smoke and mirrors through Qatar and Islamabad—every trader's watching, hoping for a ceasefire that might either stabilize or further jolt energy prices. Oil...

Continue Reading
Linker Vision's AI Platform Boosts Urban Planning

Updated Category News Views 72

Now, I've seen a fair share of tech rollouts claiming to change the world, but Linker Vision’s new AI platform, Linker AI Nexa, might actually be onto something real here. Revealed at the Smart City Expo World Congress 2026 in Barcelona, this isn't just another pretty interface—it’s packing some serious firepower with NVIDIA tech. Bringing Physical AI to City...

Continue Reading
Bright Minds Faces Legal Scrutiny Over FDA Trial Hold

Updated Category News Views 72

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....

Continue Reading
Instanodes Tackling Quantum Threats in Blockchain

Updated Category News Views 114

Diving Into Quantum Cryptography for Blockchain Instanodes is throwing down the gauntlet for the blockchain crowd as the field of quantum computing edges ever closer to unsettling the cryptographic order. This company's latest play? Post-quantum account engineering for major players like Ethereum and Solana. And it's not just tinkering—they're giving the status quo a...

Continue Reading

Top 5 Most Recently Viewed Articles

MindMaze Therapeutics: 2026 Business Update and Insights

Updated Category News Views 16

Breaking Down MindMaze’s 2026 Update Today, I’m sifting through MindMaze Therapeutics' latest half-year report like a prospector panning for gold nuggets. It’s a mixed bag, folks, full of expansion optimism underlined by a nagging loss in the financial ledger. But they say fortune favors the bold, right? The company has ambitious ideas, and their genetic makeup...

Continue Reading
Tantrum Sportfishing Celebrates Record Blue Marlin Achievement

Updated Category News Views 190

Historic Milestone for Tantrum Sportfishing In an inspiring turn of events for the sportfishing community, Tantrum Sportfishing has achieved a remarkable milestone. The Kona-based charter company announced its proud entry into the illustrious "Grander Club" after landing a colossal 1,039-pound Blue Marlin. This catch not only signifies a personal triumph for the team but...

Continue Reading
New Bitcoin ETF Offers Investors Unique Downside Protection

Updated Category News Views 227

Calamos Introduces a Groundbreaking Bitcoin ETF Investment management firm Calamos is excited to roll out an innovative approach to cryptocurrency investing with the launch of the world’s first 100% downside-protected Bitcoin exchange-traded fund (ETF). This launch comes just after an announcement suggesting that an ETF will be available for investors looking to...

Continue Reading
Exciting Developments in dsm-firmenich's Share Repurchase Initiative

Updated Category News Views 178

Progress Update on dsm-firmenich's Share Repurchase Program dsm-firmenich, known for its innovative approach in the fields of nutrition, health, and beauty, is actively implementing its large-scale share repurchase program. This initiative began earlier this year and signifies a strategic move to enhance shareholder value and manage capital effectively. Initial...

Continue Reading
Capricor Therapeutics: Key Deadlines for Shareholders to Remember

Updated Category News Views 133

Crucial Dates for Capricor Therapeutics Shareholders The Gross Law Firm has released an important notice for shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR). The firm encourages anyone who purchased shares during the specified class period to connect with them regarding possible lead plaintiff appointments. Being appointed as the lead plaintiff isn't necessary...

Continue Reading